International Business Machines (IBM) › Analysis

International Business Machines (IBM) analysis, July 15, 2026

Published July 15, 2026 · IBM chart, levels and live analysis

Key Updates

IBM shares have declined an additional 2.19% since the July 14 report to $216.06, consolidating near post-earnings crash lows following the company's catastrophic Q2 2026 earnings miss that triggered a ~25% single-session collapse. The July 14 Form 8-K confirmed results of operations disclosure, with reported Q2 revenue of $17.2 billion (+1% YoY) and EPS of $2.27 (-2% YoY), both materially below consensus estimates of $17.8 billion and higher EPS forecasts respectively. The investment thesis has materially deteriorated: HSBC has downgraded IBM to Reduce, execution failures acknowledged by CEO Arvind Krishna compound the structural demand shift away from mainframes, and the stock is now down 27.06% YTD with no technical floor yet confirmed.

Current Trend

IBM is in a pronounced and accelerating downtrend across all measured timeframes. Key performance metrics as of July 15, 2026:

The stock has failed to find a technical bid in the two sessions following the earnings collapse, suggesting that institutional selling pressure remains elevated and that no meaningful support level has yet been established at current prices.

Investment Thesis

IBM's investment thesis has historically rested on three pillars: (1) a durable hybrid cloud and AI software revenue stream anchored by the Red Hat platform, (2) resilient mainframe infrastructure demand driven by enterprise mission-critical workloads, and (3) a stable consulting business providing cross-sell leverage. The Q2 2026 results have materially undermined the second and third pillars. Infrastructure revenue declined 7% — well beyond the low single-digit decline that analysts had anticipated — as corporate clients front-loaded purchases of servers and storage ahead of anticipated AI-driven price increases, deferring mainframe spending. CEO Arvind Krishna explicitly attributed the shortfall to execution failures and delays in closing large deals, introducing significant management credibility risk. The software segment's 5% growth remains a relative positive, and new product introductions (compact z17, LinuxONE Rockhopper 5, zSecure suite) demonstrate continued R&D activity, but these cannot offset the near-term revenue and earnings damage.

Thesis Status

The investment thesis is materially impaired. The execution failure acknowledged by IBM's own CEO represents a fundamental shift in the risk profile, moving the stock from a "show-me" story to a "broken thesis" scenario in the near term. Key thesis components assessed below:

Key Drivers

The following factors are currently driving IBM's price action and fundamental outlook:

Technical Analysis

IBM is trading at $216.06, having collapsed from the pre-earnings level of approximately $295 in a near-vertical decline. The stock is now down 27.06% YTD and has breached all prior support levels identified in previous analyses. Key technical observations:

Bull Case

Bear Case

Get a message when the IBM picture changes — the agent team watches the levels and the news for you.Create a free account

More IBM analyses